том 62 издание 9 страницы 4265-4311

A Survey of the Structures of US FDA Approved Combination Drugs

Тип публикацииJournal Article
Дата публикации2018-11-16
scimago Q1
wos Q1
БС1
SJR1.801
CiteScore11.5
Impact factor6.8
ISSN00222623, 15204804
Drug Discovery
Molecular Medicine
Краткое описание
Combination drugs are an important class of US FDA approved pharmaceuticals. These drugs have been on a continuous growth trajectory since the first combination drugs were approved in the 1940s. In this Perspective, we report the first comprehensive compilation and analysis of US FDA approved combination drugs, from the first approval in 1943 through 2018. Our database contains 419 combination drugs, which are represented by 328 unique small molecule structures. Breakdown of these drugs according to disease category, structure, combination composition, and year of approval is presented as well as the top 24 most commonly used small molecule combination drug components. For frequently used small molecule components, we present "relationship diagrams" to aid in the visualization of the many drug combinations these structures are part of. The main body contains 10 disease-focused sections wherein every small molecule component utilized as part of a combination for each disease category is displayed.
Найдено 
Найдено 

Топ-30

Журналы

5
10
15
20
25
30
Organic Letters
29 публикаций, 10.62%
Journal of Organic Chemistry
10 публикаций, 3.66%
Angewandte Chemie - International Edition
9 публикаций, 3.3%
Angewandte Chemie
9 публикаций, 3.3%
European Journal of Organic Chemistry
9 публикаций, 3.3%
Chemistry - A European Journal
8 публикаций, 2.93%
Chemical Communications
8 публикаций, 2.93%
Journal of Medicinal Chemistry
7 публикаций, 2.56%
Advanced Synthesis and Catalysis
7 публикаций, 2.56%
Journal of the American Chemical Society
7 публикаций, 2.56%
RSC Advances
6 публикаций, 2.2%
ACS Catalysis
5 публикаций, 1.83%
Organic Chemistry Frontiers
5 публикаций, 1.83%
Molecules
4 публикации, 1.47%
Bioorganic Chemistry
4 публикации, 1.47%
ChemistrySelect
4 публикации, 1.47%
Chemical Science
4 публикации, 1.47%
Organic and Biomolecular Chemistry
4 публикации, 1.47%
Asian Journal of Organic Chemistry
3 публикации, 1.1%
Chinese Journal of Organic Chemistry
3 публикации, 1.1%
Pharmaceutics
3 публикации, 1.1%
Tetrahedron
3 публикации, 1.1%
Russian Chemical Reviews
3 публикации, 1.1%
Chinese Chemical Letters
3 публикации, 1.1%
Chinese Journal of Chemistry
3 публикации, 1.1%
Crystal Growth and Design
3 публикации, 1.1%
Synthesis
3 публикации, 1.1%
Medicinal Chemistry
2 публикации, 0.73%
Nature Chemistry
2 публикации, 0.73%
5
10
15
20
25
30

Издатели

10
20
30
40
50
60
70
American Chemical Society (ACS)
70 публикаций, 25.64%
Wiley
63 публикации, 23.08%
Elsevier
40 публикаций, 14.65%
Royal Society of Chemistry (RSC)
35 публикаций, 12.82%
Springer Nature
19 публикаций, 6.96%
MDPI
12 публикаций, 4.4%
Georg Thieme Verlag KG
5 публикаций, 1.83%
Frontiers Media S.A.
4 публикации, 1.47%
Oxford University Press
4 публикации, 1.47%
Bentham Science Publishers Ltd.
3 публикации, 1.1%
Shanghai Institute of Organic Chemistry
3 публикации, 1.1%
Taylor & Francis
3 публикации, 1.1%
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
3 публикации, 1.1%
Cold Spring Harbor Laboratory
3 публикации, 1.1%
OOO Zhurnal "Mendeleevskie Soobshcheniya"
1 публикация, 0.37%
American Society for Pharmacology and Experimental Therapeutics
1 публикация, 0.37%
International Union of Crystallography (IUCr)
1 публикация, 0.37%
Pleiades Publishing
1 публикация, 0.37%
Institute of Electrical and Electronics Engineers (IEEE)
1 публикация, 0.37%
10
20
30
40
50
60
70
  • Мы не учитываем публикации, у которых нет DOI.
  • Статистика публикаций обновляется еженедельно.

Вы ученый?

Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Метрики
273
Поделиться
Цитировать
ГОСТ |
Цитировать
Das P. et al. A Survey of the Structures of US FDA Approved Combination Drugs // Journal of Medicinal Chemistry. 2018. Vol. 62. No. 9. pp. 4265-4311.
ГОСТ со всеми авторами (до 50) Скопировать
Das P., Delost M. D., Qureshi M. H., Smith D. T., Njardarson J. T. A Survey of the Structures of US FDA Approved Combination Drugs // Journal of Medicinal Chemistry. 2018. Vol. 62. No. 9. pp. 4265-4311.
RIS |
Цитировать
TY - JOUR
DO - 10.1021/acs.jmedchem.8b01610
UR - https://doi.org/10.1021/acs.jmedchem.8b01610
TI - A Survey of the Structures of US FDA Approved Combination Drugs
T2 - Journal of Medicinal Chemistry
AU - Das, Pradipta
AU - Delost, Michael D
AU - Qureshi, Munaum H
AU - Smith, David T
AU - Njardarson, J. T.
PY - 2018
DA - 2018/11/16
PB - American Chemical Society (ACS)
SP - 4265-4311
IS - 9
VL - 62
PMID - 30444362
SN - 0022-2623
SN - 1520-4804
ER -
BibTex |
Цитировать
BibTex (до 50 авторов) Скопировать
@article{2018_Das,
author = {Pradipta Das and Michael D Delost and Munaum H Qureshi and David T Smith and J. T. Njardarson},
title = {A Survey of the Structures of US FDA Approved Combination Drugs},
journal = {Journal of Medicinal Chemistry},
year = {2018},
volume = {62},
publisher = {American Chemical Society (ACS)},
month = {nov},
url = {https://doi.org/10.1021/acs.jmedchem.8b01610},
number = {9},
pages = {4265--4311},
doi = {10.1021/acs.jmedchem.8b01610}
}
MLA
Цитировать
Das, Pradipta, et al. “A Survey of the Structures of US FDA Approved Combination Drugs.” Journal of Medicinal Chemistry, vol. 62, no. 9, Nov. 2018, pp. 4265-4311. https://doi.org/10.1021/acs.jmedchem.8b01610.